Format

Send to

Choose Destination
Plast Reconstr Surg Glob Open. 2016 Dec 14;4(12 Suppl Anatomy and Safety in Cosmetic Medicine: Cosmetic Bootcamp):e1155. doi: 10.1097/GOX.0000000000001155. eCollection 2016 Dec.

Noninvasive Submental Fat Compartment Treatment.

Author information

1
private practice, Ava MD, Beverly Hills and Santa Monica, Calif.

Abstract

BACKGROUND:

KYBELLA, ATX-101, is an injectable form of sodium deoxycholic acid. It is currently the only Food and Drug Administration-approved injectable drug for the reduction of submental fat.

OBJECTIVES:

A literature review and discussion of the treatment of submental fat.

RESULTS:

KYBELLA is a well-tolerated alternative for the treatment of submental fat.

CONCLUSIONS:

KYBELLA is a safe and efficacious, first in class, injectable drug for the reduction of submental fat.

Conflict of interest statement

The author has no financial interest to declare in relation to the content of this article. The Article Processing Charge for this proceeding was paid for by Allergan plc, as part of an unrestricted educational grant to support the entire Cosmetic Boot Camp 2016 Supplement. Allergan plc had no involvement in the production, selection, or review of this proceeding supplement.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center